These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32927497)

  • 61. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
    Magdy T; Schuldt AJT; Wu JC; Bernstein D; Burridge PW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():83-103. PubMed ID: 28992430
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
    Paci M; Casini S; Bellin M; Hyttinen J; Severi S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
    Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
    Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human engineered heart tissue as a model system for drug testing.
    Eder A; Vollert I; Hansen A; Eschenhagen T
    Adv Drug Deliv Rev; 2016 Jan; 96():214-24. PubMed ID: 26026976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Am80, a retinoic acid receptor agonist, activates the cardiomyocyte cell cycle and enhances engraftment in the heart.
    Kasamoto M; Funakoshi S; Hatani T; Okubo C; Nishi Y; Tsujisaka Y; Nishikawa M; Narita M; Ohta A; Kimura T; Yoshida Y
    Stem Cell Reports; 2023 Aug; 18(8):1672-1685. PubMed ID: 37451261
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of iCell cardiomyocytes using single-cell RNA-sequencing methods.
    Schmid C; Wohnhaas CT; Hildebrandt T; Baum P; Rast G
    J Pharmacol Toxicol Methods; 2020; 106():106915. PubMed ID: 32871229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns.
    Jabart E; Molho J; Sin K; Stansfield B; Kazmouz SG; Ventro D; Gardner K; Wu JC; Churko JM
    J Mol Cell Cardiol; 2020 Dec; 149():115-122. PubMed ID: 33010256
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Automated Dynamic Clamp for Simulation of I
    Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A
    Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Parikh SS; Blackwell DJ; Gomez-Hurtado N; Frisk M; Wang L; Kim K; Dahl CP; Fiane A; Tønnessen T; Kryshtal DO; Louch WE; Knollmann BC
    Circ Res; 2017 Dec; 121(12):1323-1330. PubMed ID: 28974554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel ionic model for matured and paced atrial-like human iPSC-CMs integrating I
    Botti S; Bartolucci C; Altomare C; Paci M; Barile L; Krause R; Pavarino LF; Severi S
    Comput Biol Med; 2024 Sep; 180():108899. PubMed ID: 39106668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs.
    Li W; Luo X; Ulbricht Y; Wagner M; Piorkowski C; El-Armouche A; Guan K
    Stem Cell Res; 2019 Dec; 41():101662. PubMed ID: 31809994
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.